Skip to main content
Top
Published in: Cancer Causes & Control 6/2009

01-08-2009 | Original Paper

Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada

Authors: Laura N. Anderson, Michelle Cotterchio, Steven Gallinger

Published in: Cancer Causes & Control | Issue 6/2009

Login to get access

Abstract

Objectives

Pancreatic adenocarcinoma has one of the worst survival rates of all the cancers. Established risk factors for this malignancy are smoking, body mass index (BMI) and family history of pancreatic cancer. Findings are inconsistent regarding pancreatitis, diabetes, allergies, intake of fruit, vegetables, red meat, alcohol, caffeine, vitamin C, calcium, and folate supplements. Possible pancreatic cancer risk factors were evaluated within the population-based Ontario Pancreas Cancer Study.

Methods

Pathologically confirmed pancreatic cancer cases (n = 422) were identified from the Ontario Cancer Registry between 2003 and 2007. Controls (n = 312) were recruited through random digit dialing. Data were collected using self-administered questionnaires. Multivariate logistic regression was used to obtain odds ratios.

Results

Smoking, BMI, family history of pancreatic cancer, and caffeine were significantly associated with increased pancreatic cancer risk, while fruit intake and allergies significantly decreased risk. No other significant associations were observed in the multivariate model. Effect modification by smoking status was suggested for caffeine, family history of pancreatic cancer, BMI, and fruit.

Conclusions

This study further clarifies the association between several lifestyle, dietary and medical history factors, and pancreatic cancer risk, many of which are potentially modifiable. Possible effect modification by smoking status should be further explored in future etiologic studies.
Literature
1.
go back to reference Canadian Cancer Society/National Cancer Institute of Canada (2008) Canadian Cancer Statistics 2008 Canadian Cancer Society/National Cancer Institute of Canada (2008) Canadian Cancer Statistics 2008
3.
go back to reference Colditz GA, Atwood KA, Emmons K et al (2000) Harvard report on cancer prevention volume 4: Harvard cancer risk index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 11:477–488. doi:10.1023/A:1008984432272 PubMedCrossRef Colditz GA, Atwood KA, Emmons K et al (2000) Harvard report on cancer prevention volume 4: Harvard cancer risk index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 11:477–488. doi:10.​1023/​A:​1008984432272 PubMedCrossRef
6.
go back to reference World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington
11.
go back to reference Eppel A, Cotterchio M, Gallinger S (2007) Allergies are associated with reduced pancreas cancer risk: a population-based case–control study in Ontario, Canada. Int J Cancer 121:2241–2245. doi:10.1002/ijc.22884 PubMedCrossRef Eppel A, Cotterchio M, Gallinger S (2007) Allergies are associated with reduced pancreas cancer risk: a population-based case–control study in Ontario, Canada. Int J Cancer 121:2241–2245. doi:10.​1002/​ijc.​22884 PubMedCrossRef
12.
go back to reference Merrill RM, Isakson RT, Beck RE (2007) The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol 99:102–116PubMedCrossRef Merrill RM, Isakson RT, Beck RE (2007) The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol 99:102–116PubMedCrossRef
13.
go back to reference Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P (2005) Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomark Prev 14:1908–1916. doi:10.1158/1055-9965.EPI-05-0119 CrossRef Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P (2005) Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomark Prev 14:1908–1916. doi:10.​1158/​1055-9965.​EPI-05-0119 CrossRef
15.
go back to reference Cotterchio M, McKeown-Eyssen G, Sutherland H et al (2000) Ontario familial colon cancer registry: methods and first-year response rates. Chronic Dis Can 21:81–86PubMed Cotterchio M, McKeown-Eyssen G, Sutherland H et al (2000) Ontario familial colon cancer registry: methods and first-year response rates. Chronic Dis Can 21:81–86PubMed
16.
go back to reference SAS Institute Inc (2005) SAS 9.1. Windows version SAS Institute Inc (2005) SAS 9.1. Windows version
18.
19.
go back to reference Hanley AJ, Johnson KC, Villeneuve PJ, Mao Y, Canadian Cancer Registries Epidemiology Research Group (2001) Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system. Int J Cancer 94:140–147. doi:10.1002/ijc.1446 PubMedCrossRef Hanley AJ, Johnson KC, Villeneuve PJ, Mao Y, Canadian Cancer Registries Epidemiology Research Group (2001) Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system. Int J Cancer 94:140–147. doi:10.​1002/​ijc.​1446 PubMedCrossRef
20.
go back to reference Permuth-Wey J, Egan KM (2008) Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer Sep 2. Epub ahead of print Permuth-Wey J, Egan KM (2008) Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer Sep 2. Epub ahead of print
23.
24.
28.
go back to reference Harnack LJ, Anderson KE, Zheng W, Folsom AR, Sellers TA, Kushi LH (1997) Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Women’s Health Study. Cancer Epidemiol Biomark Prev 6:1081–1086 Harnack LJ, Anderson KE, Zheng W, Folsom AR, Sellers TA, Kushi LH (1997) Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Women’s Health Study. Cancer Epidemiol Biomark Prev 6:1081–1086
29.
go back to reference Ghadirian P, Simard A, Baillargeon J (1991) Tobacco, alcohol, and coffee and cancer of the pancreas: a population-based, case–control study in Quebec, Canada. Cancer 67:2664–2670. doi:10.1002/1097-0142(19910515)67:10<2664::AID-CNCR2820671043>3.0.CO;2-KPubMedCrossRef Ghadirian P, Simard A, Baillargeon J (1991) Tobacco, alcohol, and coffee and cancer of the pancreas: a population-based, case–control study in Quebec, Canada. Cancer 67:2664–2670. doi:10.1002/1097-0142(19910515)67:10<2664::AID-CNCR2820671043>3.0.CO;2-KPubMedCrossRef
30.
go back to reference Villeneuve PJ, Johnson KC, Hanley AJ, Mao Y (2000) Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case–control project. Canadian Cancer Registries Epidemiology Research Group. Eur J Cancer Prev 9:49–58. doi:10.1097/00008469-200002000-00007 PubMedCrossRef Villeneuve PJ, Johnson KC, Hanley AJ, Mao Y (2000) Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case–control project. Canadian Cancer Registries Epidemiology Research Group. Eur J Cancer Prev 9:49–58. doi:10.​1097/​00008469-200002000-00007 PubMedCrossRef
31.
go back to reference Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2001) Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomark Prev 10:429–437 Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2001) Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomark Prev 10:429–437
33.
go back to reference Larsson SC, Bergkvist L, Wolk A (2006) Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study. Am J Clin Nutr 84:1171–1176PubMed Larsson SC, Bergkvist L, Wolk A (2006) Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study. Am J Clin Nutr 84:1171–1176PubMed
34.
35.
go back to reference Zheng W, McLaughlin JK, Gridley G et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 4:477–482. doi:10.1007/BF00050867 PubMedCrossRef Zheng W, McLaughlin JK, Gridley G et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 4:477–482. doi:10.​1007/​BF00050867 PubMedCrossRef
36.
go back to reference Silverman DT, Brown LM, Hoover RN et al (1995) Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res 55:4899–4905PubMed Silverman DT, Brown LM, Hoover RN et al (1995) Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res 55:4899–4905PubMed
40.
go back to reference Tavani A, Pregnolato A, Negri E, La Vecchia C (1997) Alcohol consumption and risk of pancreatic cancer. Nutr Cancer 27:157–161PubMedCrossRef Tavani A, Pregnolato A, Negri E, La Vecchia C (1997) Alcohol consumption and risk of pancreatic cancer. Nutr Cancer 27:157–161PubMedCrossRef
42.
go back to reference Nkondjock A, Krewski D, Johnson KC, Ghadirian P, Canadian Cancer Registries Epidemiology Research Group (2005) Dietary patterns and risk of pancreatic cancer. Int J Cancer 114:817–823. doi:10.1002/ijc.20800 PubMedCrossRef Nkondjock A, Krewski D, Johnson KC, Ghadirian P, Canadian Cancer Registries Epidemiology Research Group (2005) Dietary patterns and risk of pancreatic cancer. Int J Cancer 114:817–823. doi:10.​1002/​ijc.​20800 PubMedCrossRef
43.
go back to reference Nkondjock A, Krewski D, Johnson KC, Ghadirian P, Canadian Cancer Registries Epidemiology Research Group (2005) Specific fatty acid intake and the risk of pancreatic cancer in Canada. Br J Cancer 92:971–977. doi:10.1038/sj.bjc.6602380 PubMedCrossRef Nkondjock A, Krewski D, Johnson KC, Ghadirian P, Canadian Cancer Registries Epidemiology Research Group (2005) Specific fatty acid intake and the risk of pancreatic cancer in Canada. Br J Cancer 92:971–977. doi:10.​1038/​sj.​bjc.​6602380 PubMedCrossRef
44.
go back to reference Nkondjock A, Ghadirian P, Johnson KC, Krewski D, Canadian Cancer Registries Epidemiology Research Group (2005) Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr 135:592–597PubMed Nkondjock A, Ghadirian P, Johnson KC, Krewski D, Canadian Cancer Registries Epidemiology Research Group (2005) Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr 135:592–597PubMed
45.
go back to reference Ghadirian P, Baillargeon J, Simard A, Perret C (1995) Food habits and pancreatic cancer: a case–control study of the Francophone community in Montreal, Canada. Cancer Epidemiol Biomark Prev 4:895–899 Ghadirian P, Baillargeon J, Simard A, Perret C (1995) Food habits and pancreatic cancer: a case–control study of the Francophone community in Montreal, Canada. Cancer Epidemiol Biomark Prev 4:895–899
47.
go back to reference Rothman KJ, Greenland S (1998) Modern epidemiology. Lippincott-Raven, Philadelphia, PA, p 127 Rothman KJ, Greenland S (1998) Modern epidemiology. Lippincott-Raven, Philadelphia, PA, p 127
Metadata
Title
Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada
Authors
Laura N. Anderson
Michelle Cotterchio
Steven Gallinger
Publication date
01-08-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 6/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9303-5

Other articles of this Issue 6/2009

Cancer Causes & Control 6/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine